ISPC Stock Analysis: Buy, Sell, or Hold?
ISPC - iSpecimen Inc. Common Stock
$1.69
-0.58 (-25.55%)
▼
5d:
-24.89%
30d:
-24.22%
90d:
-52.66%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ISPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ISPC is down 24.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ISPC is down 24.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ISPC is currently trading at $1.69, which is considered oversold relative to its 30-day fair value range of $1.97 to $2.33.
Technical Outlook: Technically, ISPC is showing sideways momentum. Immediate support is located at $1.56, while resistance sits at $2.59. Short-term momentum is weak, with the stock down 25.6% recently.
Market Sentiment: ISPC scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+77.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISPC is showing sideways momentum. Immediate support is located at $1.56, while resistance sits at $2.59. Short-term momentum is weak, with the stock down 25.6% recently.
Market Sentiment: ISPC scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+77.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.97 -
$2.33
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-25.6%)
- BULLISH: Trading 77.5% below Wall St target ($3.00)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.97 -
$2.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.57
Resistance Level
$2.59
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$3.00
(+77.5%)
Revenue Growth (YoY)
-85.2%
Share & Embed Analysis
Last updated: August 24, 2026 9:21 AM ET
Data refreshes hourly during market hours. Next update: 10:21 AM
Data refreshes hourly during market hours. Next update: 10:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 38 SELL |
